Not long after lending its support…
Not long after lending its support to a documentary aimed [...]
The status of the CDC’s vaccine…
The status of the CDC’s vaccine advisory panel was thrown [...]
The new FDA nod makes Rhythm…
The new FDA nod makes Rhythm Pharma’s Imcivree the first [...]
Novartis has struck a deal to buy…
Novartis has struck a deal to buy Synnovation Therapeutics’ pan-mutant‑selective [...]
Gilead has handed back a next-gen…
Gilead has handed back a next-gen hepatitis B antiviral to [...]
Renowned cardiologist Eric Topol,…
Renowned cardiologist Eric Topol, M.D., is setting sail with Flagship [...]
The company is working with…
The company is working with regulators to ensure stable ongoing [...]
China approved the world’s first…
China approved the world’s first commercial brain-computer interface. AstraZeneca is [...]
Genentech has elected to stop a…
Genentech has elected to stop a phase 2 trial of [...]
Still basking in the afterglow of…
Still basking in the afterglow of its Wegovy pill launch [...]